Pharma
Contract manufacturer of specialist pharmaceutical catalysts at both small and medium scale for the pharmaceutical market.
Routine supply of pharma catalysts
Enzymes are used as catalysts for the production of active pharmaceutical ingredients (APIs) and intermediates. We have built a strong reputation within the pharma industry specialising in the technical transfer of enzyme expression, fermentation and downstream processing at commercial volumes.
Resources
View All
27 Feb 2023
BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
With the enzyme activities of the group focusing on food, beverage and healthcare, combined with BRAIN Biotech's strong scientific roots, the Group are well positioned to service global megatrends from the production of better and healthier foods to sustainable industrialisation.
16 Jan 2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22
Despite a challenging geopolitical environment, BRAIN Biotech announce strong sales laying the foundations for ongoing future dynamic growth.
18 Nov 2022
Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!
We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
14 Oct 2021
Biocatalysts Ltd Announce Plans for Further Investment for Second 10m³ Fermenter in Cardiff
The introduction of a second 10m³ fermenter enables Biocatalysts Ltd.’s manufacturing site in Cardiff to act as a pilot plant for medium-scale production and optimised tech-transfer for larger industrial scale fermentation.
4 Nov 2020
Winners of Prestigious IChemE Global Food & Drink Award 2020
IChemE have selected Biocatalysts Ltd in partnership with University College London (UCL) as the winners of the prestigious IChemE Global Food & Drink Award 2020, for our submission – Ultra Scale-Down Accelerates Industrial Enzyme Manufacture.
Case Study
Partnering with a Global Pharmaceutical Company for Large Scale Enzyme Manufacturing
A large pharmaceutical company needed an enzyme manufacturing partner to develop their enzymes from lab to commercial scales.
Case Study
Dramatically Improving Enzyme Recovery using Ultra-Scale Down Techniques
Optimisation of downstream processing is just as important as optimising the fermentation process itself to increase the recovery of the enzyme.
23 Apr 2019
Winners of Prestigious Queen's Award for Enterprise in Innovation
This prestigious award is in recognition of Biocatalysts’ drive and enlightened approach to providing the best enzyme solutions to their customers, through development of a bespoke software system MetXtra™, capable of screening millions of sequences to identify new enzymes in just a few hours.
Customised Enzyme Development & Manufacture
Biocatalysts Ltd helps many pharmaceutical clients at various stages of enzyme discovery, product-development, scale-up, and supply, for applications in a wide range of processes. We have built a standalone business model specifically to support this approach, leveraging our short response times, our history in commercialising novel enzymes, and our lab-to-plant manufacturing scales. This minimises risk when commercialising enzymes for pharmaceutical applications, and ensures we can support existing R&D and campaign projects seamlessly.
